Literature DB >> 31944403

Brainstem ventilatory dysfunction: A plausible mechanism for dyspnea in Parkinson's Disease?

Srimathy Vijayan1, Bhajan Singh2,3, Soumya Ghosh1, Rick Stell1, Frank L Mastaglia1.   

Abstract

Dyspnea is an under-recognized and debilitating symptom that is reported in up to 40% of patients with Parkinson's disease and may have multiple origins. Despite its frequency, it is poorly researched, and there is a general lack of understanding of the pathophysiology of dyspnea and respiratory dysfunction in PD. Consequently, a number of PD patients are labelled as having "unexplained dyspnea." Studies to date have focused mainly on evaluating ventilatory capacity and lung volumes, and little is known about the effects of the disease on the medullary and pontine ventilatory control centers within the brainstem. This is of particular relevance in view of neuropathological studies demonstrating early involvement of the dorsal medulla and other brainstem structures by the disease process. The possibility that impaired brainstem ventilatory control is a contributory mechanism for dyspnea and could be a premotor manifestation in some PD patients therefore warrants further attention. This review focuses on clinical, pathological, and experimental evidence for the involvement of brainstem respiratory centers in PD. We highlight the need for further research, particularly in PD patients with unexplained dyspnea.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; brainstem ventilatory dysfunction; control of ventilation; dyspnea; non-motor symptom

Mesh:

Year:  2020        PMID: 31944403     DOI: 10.1002/mds.27932

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Treatment paradigms in Parkinson's Disease and Covid-19.

Authors:  Iro Boura; Lucia Batzu; Espen Dietrichs; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-05-28       Impact factor: 4.280

2.  Experienced Respiratory Symptoms and the Impact on Daily Life from the Perspective of People with Parkinson's Disease: A Grounded Theory.

Authors:  Veerle A van de Wetering-van Dongen; Maarten J Nijkrake; Niek Koenders; Philip J van der Wees; Bastiaan R Bloem; Johanna G Kalf
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Effects of an Aquatic Physical Exercise Program on Ventilatory Parameters in People with Parkinson's Disease.

Authors:  Bruna Yamaguchi; Dielise Debona Iucksch; Luis Henrique Paladini; Vera Lúcia Israel
Journal:  Parkinsons Dis       Date:  2022-08-31

4.  Deficiency of Biogenic Amines Modulates the Activity of Hypoglossal Nerve in the Reserpine Model of Parkinson's Disease.

Authors:  Monika Jampolska; Kryspin Andrzejewski; Małgorzata Zaremba; Ilona Joniec-Maciejak; Katarzyna Kaczyńska
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

Review 5.  Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.

Authors:  Roberto Cilia; Salvatore Bonvegna; Giulia Straccia; Nico Golfrè Andreasi; Antonio E Elia; Luigi M Romito; Grazia Devigili; Emanuele Cereda; Roberto Eleopra
Journal:  Mov Disord       Date:  2020-06-11       Impact factor: 9.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.